今天，5个超级IPO敲钟！CFO履历亮眼！

Core Viewpoint - The Hong Kong Stock Exchange welcomed five IPOs today, including Junsheng Electronics, WeRide, Pony.ai, Wangshan Wangshui, and Daming Electronics, reflecting a vibrant IPO market. Group 1: Junsheng Electronics - Junsheng Electronics successfully listed on the Hong Kong Stock Exchange, focusing on automotive electronic and safety solutions, ranking 41st globally in the automotive parts industry in 2024 [6][12]. - The company reported revenues of RMB 497.9 billion and RMB 557.28 billion for 2022 and 2023, respectively, with a net profit of RMB 2.33 billion in 2022 and RMB 12.4 billion in 2023 [6][12]. - Junsheng's revenue for Q3 2025 was RMB 154.97 billion, a year-on-year increase of 10.25%, with a net profit of RMB 4.13 billion, up 35.4% [6][12]. Group 2: WeRide - WeRide completed its IPO on the Hong Kong Stock Exchange, becoming the first "Robotaxi" stock in Hong Kong, with an issue price of HKD 27.1 per share [14]. - The company is a global leader in L4 autonomous driving, operating in over 30 cities across 11 countries, and holds a 21.8% market share in the L4 autonomous driving sector [14][15]. - WeRide's revenue for 2022, 2023, and 2024 was RMB 5.28 billion, RMB 4.02 billion, and RMB 3.61 billion, respectively, with a significant loss recorded in 2024 of RMB 25.17 billion [16][17]. Group 3: Pony.ai - Pony.ai achieved a dual listing on the Hong Kong Stock Exchange, raising up to HKD 77 billion, marking the largest IPO in the global autonomous driving sector in 2025 [23]. - The company operates over 720 Robotaxis in major Chinese cities and has launched its seventh-generation Robotaxi, which utilizes 100% automotive-grade components [24][25]. - In Q2 2025, Pony.ai's Robotaxi business revenue surged by 157.8% year-on-year to RMB 10.9 million, driven by increased user demand and vehicle deployment [24][25]. Group 4: Wangshan Wangshui - Wangshan Wangshui, a biopharmaceutical company, listed on the Hong Kong Stock Exchange, focusing on small molecule drugs in neuropsychiatric and reproductive health [30][31]. - The company has developed two core products targeting significant clinical needs in their respective markets and has a diverse pipeline of nine innovative assets [30][31]. - Wangshan Wangshui reported revenues of RMB 200 million and RMB 118.32 million for 2023 and 2024, respectively, with a net loss of RMB 218 million in 2024 [32]. Group 5: Daming Electronics - Daming Electronics officially listed on the Shanghai Stock Exchange, specializing in automotive electronic components with a strong client base including major automakers [36][37]. - The company has shown consistent growth, with revenues increasing from RMB 1.713 billion in 2022 to RMB 2.727 billion in 2024, and net profits rising from RMB 151 million to RMB 282 million during the same period [37].